SARS‐CoV‐2 Genome and S2 Spike Protein: IRF‐Driven Interferon Regulation and Host Cell Responses
Reviews in Medical Virology · 2026
DOI: 10.1002/rmv.70094 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Reviews in Medical Virology, 2026. Verfasst von Ekta Singh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Recombinant DNA Technology Laboratory, Department of Biotechnology, Central University of South Bihar, Gaya, India. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, SARS-CoV-2, COVID-19, Interferon Regulatory Factor-1. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 254 Literaturangaben.
Abstract (Originalsprache)
Coronaviruses, members of the betacoronavirus genus. They are mostly enveloped and has +ve sense RNA which infects a wide range of hosts, including mammals and birds. This SARS‐CoV‐2 in December 2019 triggered a global pandemic, with transmission primarily occurring through respiratory droplets. SARS‐CoV‐2 comprises four structural proteins namely: spike, membrane, envelope and nucleocapsid protein (S, M, E, and N respectively) along with multiple non‐structural proteins (nsp1–nsp16) essential for infections. The trimeric S protein, composed of S1 and S2 subunits which helps in virus entry into the cell after attachment to the ACE2 recpetor of host cell. Interferon regulatory factors (IRF‐1 and IRF‐2) are critical transcription factors in antiviral immune responses, yet their specific roles in SARS‐CoV‐2 infection remain insufficiently understood. Disruption of their regulatory functions may compromise host antiviral defenses and influence disease progression. Elucidating the mechanistic roles of IRF‐1 and IRF‐2 could facilitate the production of novel therapeutic strategies which further modulates the immune responses, mitigates the viral pathogenicity, and hence clinical outcomes will be improved. A deep insight of these immune pathways is pivotal for designing targeted interventions to strengthen host resilience against coronavirus infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Recombinant DNA Technology Laboratory, Department of Biotechnology, Central University of South Bihar, Gaya, India.
ORCID-Profile: Ekta Singh
Zitieren
APA
Singh, E., Nishi, N., Tripathi, M., & Prakash, K. (2026). SARS‐CoV‐2 Genome and S2 Spike Protein: IRF‐Driven Interferon Regulation and Host Cell Responses. Reviews in Medical Virology. https://doi.org/10.1002/rmv.70094
Vancouver
Singh E, Nishi N, Tripathi M, Prakash K. SARS‐CoV‐2 Genome and S2 Spike Protein: IRF‐Driven Interferon Regulation and Host Cell Responses. Reviews in Medical Virology. 2026. doi:10.1002/rmv.70094
BibTeX
@article{Singh2026,
author = {Singh, Ekta and Nishi, Nishita and Tripathi, Mudita and Prakash, Krishna},
title = {SARS‐CoV‐2 Genome and S2 Spike Protein: IRF‐Driven Interferon Regulation and Host Cell Responses},
journal = {Reviews in Medical Virology},
year = {2026},
doi = {10.1002/rmv.70094}
}
EUVIMED